These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39245149)

  • 1. Resistance-based directed evolution of nanobodies for higher affinity in prokaryotes.
    Hu Y; Huo L; Chen W; Shen J; Wang W
    Biochim Biophys Acta Gen Subj; 2024 Nov; 1868(11):130710. PubMed ID: 39245149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering and characterization of GFP-targeting nanobody: Expression, purification, and post-translational modification analysis.
    Weng D; Yang L; Xie Y
    Protein Expr Purif; 2024 Sep; 221():106501. PubMed ID: 38782081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and comparison of two peptide-tag specific nanobodies for immunoaffinity chromatography.
    Ren J; Zhang C; Ji F; Jia L
    J Chromatogr A; 2020 Aug; 1624():461227. PubMed ID: 32540069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays.
    Lu Q; Li X; Zhao J; Zhu J; Luo Y; Duan H; Ji P; Wang K; Liu B; Wang X; Fan W; Sun Y; Zhou EM; Zhao Q
    J Nanobiotechnology; 2020 Jan; 18(1):7. PubMed ID: 31910833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Nanobody of PEDV S1 Protein: Screening and Expression in
    Hao Z; Dong X; Zhang Z; Qin Z
    Biomolecules; 2024 Sep; 14(9):. PubMed ID: 39334881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface display of a single-domain antibody library on Gram-positive bacteria.
    Fleetwood F; Devoogdt N; Pellis M; Wernery U; Muyldermans S; Ståhl S; Löfblom J
    Cell Mol Life Sci; 2013 Mar; 70(6):1081-93. PubMed ID: 23064703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide barcoding for one-pot evaluation of sequence-function relationships of nanobodies.
    Matsuzaki Y; Aoki W; Miyazaki T; Aburaya S; Ohtani Y; Kajiwara K; Koike N; Minakuchi H; Miura N; Kadonosono T; Ueda M
    Sci Rep; 2021 Nov; 11(1):21516. PubMed ID: 34728738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.
    Ferrari D; Garrapa V; Locatelli M; Bolchi A
    Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies.
    Chen X; Gentili M; Hacohen N; Regev A
    Nat Commun; 2021 Sep; 12(1):5506. PubMed ID: 34535642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobody affinity improvement: Directed evolution of the anti-ochratoxin A single domain antibody.
    Wang X; Chen Q; Sun Z; Wang Y; Su B; Zhang C; Cao H; Liu X
    Int J Biol Macromol; 2020 May; 151():312-321. PubMed ID: 32084462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TARSyn: Tunable Antibiotic Resistance Devices Enabling Bacterial Synthetic Evolution and Protein Production.
    Rennig M; Martinez V; Mirzadeh K; Dunas F; Röjsäter B; Daley DO; Nørholm MHH
    ACS Synth Biol; 2018 Feb; 7(2):432-442. PubMed ID: 29257878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered high-affinity nanobodies recognizing staphylococcal Protein A and suitable for native isolation of protein complexes.
    Fridy PC; Thompson MK; Ketaren NE; Rout MP
    Anal Biochem; 2015 May; 477():92-4. PubMed ID: 25707320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody.
    Valenzuela Nieto G; Jara R; Watterson D; Modhiran N; Amarilla AA; Himelreichs J; Khromykh AA; Salinas-Rebolledo C; Pinto T; Cheuquemilla Y; Margolles Y; López González Del Rey N; Miranda-Chacon Z; Cuevas A; Berking A; Deride C; González-Moraga S; Mancilla H; Maturana D; Langer A; Toledo JP; Müller A; Uberti B; Krall P; Ehrenfeld P; Blesa J; Chana-Cuevas P; Rehren G; Schwefel D; Fernandez LÁ; Rojas-Fernandez A
    Sci Rep; 2021 Feb; 11(1):3318. PubMed ID: 33558635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of epitope-targeting nanobody based on native protein-protein interactions for FtsZ filamentation suppressor.
    Nakazawa H; Katsuki T; Matsui T; Tsugita A; Yokoyama T; Ito T; Kawada S; Tanaka Y; Umetsu M
    Biotechnol J; 2023 Nov; 18(11):e2300039. PubMed ID: 37458140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies.
    Julian MC; Lee CC; Tiller KE; Rabia LA; Day EK; Schick AJ; Tessier PM
    Protein Eng Des Sel; 2015 Oct; 28(10):339-50. PubMed ID: 26386257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic analysis of allosteric and non-allosteric effects arising from nanobody binding to two epitopes of the dihydrofolate reductase of Escherichia coli.
    Oyen D; Wechselberger R; Srinivasan V; Steyaert J; Barlow JN
    Biochim Biophys Acta; 2013 Oct; 1834(10):2147-57. PubMed ID: 23911607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity enhancement of nanobody binding to EGFR: in silico site-directed mutagenesis and molecular dynamics simulation approaches.
    Farasat A; Rahbarizadeh F; Hosseinzadeh G; Sajjadi S; Kamali M; Keihan AH
    J Biomol Struct Dyn; 2017 Jun; 35(8):1710-1728. PubMed ID: 27691399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional mutations in and characterization of VHH against Helicobacter pylori urease.
    Hoseinpoor R; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Shahi B
    Appl Biochem Biotechnol; 2014 Mar; 172(6):3079-91. PubMed ID: 24492955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical teaching course in directed protein evolution using the green fluorescent protein as a model.
    Ruller R; Silva-Rocha R; Silva A; Cruz Schneider MP; Ward RJ
    Biochem Mol Biol Educ; 2011; 39(1):21-7. PubMed ID: 21433249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated computational pipeline for designing high-affinity nanobodies with expanded genetic codes.
    Padhi AK; Kumar A; Haruna KI; Sato H; Tamura H; Nagatoishi S; Tsumoto K; Yamaguchi A; Iraha F; Takahashi M; Sakamoto K; Zhang KYJ
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34415295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.